1. Home
  2. NVRO

as 03-31-2025 9:53am EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Medical/Dental Instruments

Nasdaq

Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. The company generates the majority of its revenue in the United States.

Founded: 2006 Country:
United States
United States
Employees: N/A City: REDWOOD CITY
Market Cap: 221.2M IPO Year: 2014
Target Price: $7.24 AVG Volume (30 days): 1.3M
Analyst Decision: Hold Number of Analysts: 12
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -3.06 EPS Growth: N/A
52 Week Low/High: $3.17 - $14.43 Next Earning Date: 03-04-2025
Revenue: $408,518,000 Revenue Growth: -3.92%
Revenue Growth (this year): 1.55% Revenue Growth (next year): 4.36%

NVRO Daily Stock ML Predictions

Share on Social Networks: